| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |